Citation Impact
Citing Papers
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
2002
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.
1987
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma
2002
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
1999
Why Don't Physicians Follow Clinical Practice Guidelines?
1999 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN
1989
Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
1996
The Effect of Timing of Ondansetron Administration on Its Efficacy, Cost-Effectiveness, and Cost-Benefit as a Prophylactic Antiemetic in the Ambulatory Setting
1998
Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics
1991
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
1997 Standout
A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
2003 Standout
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
2004 Standout
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide
1991
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Head and neck cancer
2008 Standout
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
1990
Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
1990
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
2004
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.
1989
Esophageal Cancer
2003 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Metastasis prevention by targeting the dormant niche
2015
Immunocytochemical Analysis of Estrogen Receptors in Human Breast Carcinomas
1990
Ondansetron versus Chlorpromazine for Preventing Emesis in Bone Marrow Transplant Recipients: a Double-Blind Randomized Study
1993
Detection of estrogen receptor in bone marrow from patients with metastatic breast cancer.
1987
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy
1991
Extended Lymph-Node Dissection for Gastric Cancer
1999 Standout
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Endocrine Therapies for Patients with Recurrent Breast Cancer: Predictive Factors for Responses to First- and Second-Line Endocrine Therapies
2000
Oesophageal carcinoma
2013 Standout
Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial
1996
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin.
1989
A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer
2005
Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.
1987
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Immunohistochemical localization of c-erbB-2 in human breast carcinomas
1987
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Carboplatin: current status and future prospects
1988
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Emerging Biological Principles of Metastasis
2017 Standout
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening
2003
The Impact of Patient Management Guidelines on the Care of Breast, Colorectal, and Ovarian Cancer Patients in Italy
1991
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
1990
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
Gastric cancer
2020 Standout
5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala
1992
Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting
1990
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer
1992
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
1999
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
1991
A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer
2012
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Bleeding Peptic Ulcer
1994 Standout
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
2000 Standout
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
5‐HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret
1989
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.
1996
The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy
1988
Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide
2004
The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret
1993
Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
1987
Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
1996
Preservation of Fertility in Patients with Cancer
2009 Standout
Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species
1989
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Cancer of the Ovary
2004 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Chemistry of Polyvalent Iodine
2008 Standout
Facile One‐Pot Synthesis of 2‐Aryl‐substituted Nitriles and 2‐Aryl‐3‐keto Nitriles via Benzyne Reaction
2006
A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind study
1990
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients
1982
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
1991 StandoutScienceNobel
Female Reproductive Potential after Treatment for Hodgkin's Disease
1981 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
1993 StandoutNobel
Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation
1976
Radiotherapy After Segmental Resection of Breast Cancer With Favorable Prognostic Features: 12-Year Follow-Up Results of a Randomized Trial
2008
Cancer chemotherapy by continuous intraarterial infusion of antimetabolites
1963
Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).
1995
Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.
1988
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
1987 Standout
Aplastic Anemia
1982 StandoutNobel
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
1992 Standout
Genetic epidemiology of breast cancer
1994
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer. A randomized trial of the piedmont oncology association
1982
Neuropharmacology of emesis induced by anti-cancer therapy
1988
Basic principles in the use of adjuvant therapy.
1990
Bone metastases and breast cancer
1985
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
The influence of radiation on fertility in man
1980
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
8 The neurophysiology of vomiting
1988
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 StandoutScience
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy
1982
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Randomised trial of endoscopic argon laser photocoagulation in bleeding peptic ulcers.
1981
Ifosfamide in refractory male germ cell tumors.
1986
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
2002
Works of H.T. Ford being referenced
Survey of treatment of primary breast cancer in Great Britain.
1985
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
1994
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
1990
PROSPECTIVE RANDOMISED TRIAL OF TAMOXIFEN VERSUS SURGERY IN ELDERLY PATIENTS WITH BREAST CANCER
1988
The influence of extent and local management on the outcome of radiotherapy for brain metastases
1990
Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up
1991
Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.
1987
The importance of the resection margin in conservative surgery for breast cancer
1996
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
2005
PREDICTION OF ENDOCRINE RESPONSE IN BREAST CANCER BY IMMUNOCYTOCHEMICAL DETECTION OF OESTROGEN RECEPTOR IN FINE-NEEDLE ASPIRATES
1987
TREATMENT OF DISSEMINATED BREAST CANCER WITH TAMOXIFEN, AMINOGLUTETHIMIDE, HYDROCORTISONE, AND DANAZOL, USED IN COMBINATION OR SEQUENTIALLY
1984
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen
1981
PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMA
1980
The results of radiotherapy for Hodgkin's disease
1975
PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
1987
Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
1981
Assessment of response of bone metastases to systemic treatment in patients with breast cancer
1983
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
1987
Bilateral carcinoma of the breast
1980
Recurrent Cancer of Head and Neck
1962
FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCER
1980
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma
1985
Aminoglutethimide for the treatment of advanced postmenopausal breast cancer
1983